{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001548","form_type":"8-K","ticker":"TGNT","cik":"0000846377","company_name":"Totaligent, Inc.","filed_at":"2026-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.816577+00:00","generated_at":"2026-05-15T09:18:17.876133+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Totaligent extends target date for Aetherium Medical acqui-hire to April 10, 2026","bullets":["Extension Amendment moves negotiation and closing deadline from March 5, 2026 to April 10, 2026.","Exclusivity period with Aetherium Medical extended through April 10, 2026.","Transaction involves Totaligent acquiring Aetherium's team, IP, and assets in exchange for equity.","Delay attributed to ongoing due diligence and preparatory matters."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001548","json":"https://secwatch.observer/filing/0001477932-26-001548.json","markdown":"https://secwatch.observer/filing/0001477932-26-001548.md","text":"https://secwatch.observer/filing/0001477932-26-001548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001548/0001477932-26-001548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001548/totaligent_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:18:17.876133+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"991989cd19d7422860f9be833875d5dcfd319014","claim":"Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001548/0001477932-26-001548-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Aetherium Medical"},{"label":"Effective","value":"2026-03-04"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}